![](https://ml.globenewswire.com/media/a38635e2-6d55-452d-ba94-47552b9bc1b7/small/download-png.png)
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic ...
Hamilton, Bermuda, July 19, 2024 (GLOBE NEWSWIRE) -- Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdominal aortic aneurysm Altamira’s SemaPhore™ nanoparticles delivering SOD2 mRNA …